Key Highlights

• Medline reported Q3 2026 net sales of $7.9 billion, a 10.4% year-over-year increase, with Organic Sales growth of 10.5%

• Q3 Adjusted EBITDA rose 11.8% to $960 million, while GAAP Net Income declined 1.2% to $318 million

• The company raised its full-year 2026 organic sales guidance to 10.0%–10.5%, up from 9.0%–10.0%, and reaffirmed Adjusted EBITDA guidance of $3.3–$3.4 billion

• Medline's board authorized a $1 billion share repurchase program

Medline Inc. (NASDAQ:MDLN), the largest provider of medical-surgical products and Supply chain solutions serving all points of care, reported third-quarter 2026 results that combined continued double-digit Revenue growth with Margin pressures tied to inflation, Tariff impacts, and a distribution center fire earlier in the year.

Third-Quarter Revenue Performance

Net sales for the third quarter reached $7.9 billion, up 10.4% from $7.1 billion in the prior-year period. Organic sales grew 10.5%, driven primarily by existing customer growth and the implementation of new customer signings secured in 2025. The quarter's revenue included an $11 million increase related to an adjustment of customer repayment amounts. CEO Jim Boyle attributed the results to continued commercial execution and noted the company is making progress toward its annual total new customer signings goal.

Earnings and Profitability Dynamics

While revenue growth was notable, profitability faced several crosscurrents during the quarter. GAAP net income edged lower by 1.2% to $318 million, compared with $322 million in Q3 2025. The modest decline reflected increased inventory costs associated with inflation, higher operating expenses, and shifts in customer mix, partially offset by higher net sales and net IEEPA tariff refund benefits. Adjusted EBITDA, however, increased 11.8% to $960 million from $859 million in the year-ago quarter, also benefiting from higher sales and tariff refund benefits. Q3 diluted EPS on a GAAP basis was $0.22, while Adjusted Diluted EPS came in at $0.44.

Nine-Month Trends and the Tracy Fire Impact

For the nine-month period ended September 26, 2026, net sales totaled $22.9 billion, up 10.9% from $20.6 billion in the comparable 2025 period. However, nine-month GAAP net income fell 28.8% to $696 million from $977 million, reflecting net losses of $316 million related to a fire at the company's distribution center in Tracy, California, along with higher operating expenses, tariff-related cost increases, and inflation-driven inventory costs. Nine-month Adjusted EBITDA grew 5.0% to $2.8 billion.

The Tracy fire, which occurred earlier in 2026, has had a measurable impact on the company's reported earnings. While insurance recoveries may partially offset these losses over time, the incident underscores the operational risks inherent in managing a large-scale distribution network.

Updated Guidance and Capital Return

Medline raised its full-year 2026 organic sales growth guidance to 10.0%–10.5%, up from the prior range of 9.0%–10.0%, reflecting the sustained momentum in customer wins and commercial execution. The company reaffirmed its Adjusted EBITDA guidance of $3.3 billion to $3.4 billion for the full year. Additionally, the Board of Directors authorized a $1 billion share repurchase program, signaling management's confidence in the company's cash generation capabilities and capital allocation priorities. Medline also reported continued Investment in capacity expansion and new technology across its distribution network, alongside global quality initiatives.

The Takeaway

Medline's Q3 2026 results illustrate a company navigating a complex operating environment where top-line growth continues to outpace broader market trends, even as profitability faces near-term pressure from inflation, tariff-related costs, and the Tracy fire impact. The raised organic sales guidance and newly authorized share repurchase program suggest management views the current growth trajectory as sustainable, with capital allocation increasingly oriented toward returning value to shareholders alongside ongoing infrastructure investment.